Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Financial Position

v3.22.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current:    
Cash and cash equivalents $ 37,226 $ 79,107
Restricted cash 473 353
Accounts receivable, net 2,222 1,676
Prepaids, advances and other 2,668 3,174
Other receivables 2,396 1,306
Inventories, net 15,408 10,190
Total current assets 60,393 95,806
Investment – Cansativa 1,458 1,553
Property, plant and equipment, net of accumulated depreciation of $5,702 and $3,356 for the years ended December 31, 2021 and 2020, respectively 30,932 25,680
Intangible assets, net 23,117 24,279
Goodwill 0 18,508
Other non-current assets 260 52
Total Assets 116,160 165,878
Current:    
Accounts payable 3,981 4,429
Accrued expense and other current liabilities 2,898 4,865
Loans and borrowings, current portion 949 880
Warrant liability 2,205 19,061
Deferred revenue 653 870
Total current liabilities 27,245 30,105
Loans and borrowings 6,447 5,821
Deferred revenue 1,548 1,167
Deferred tax liabilities 6,650 5,700
Other long-term liabilities 360 693
Total Liabilities 43,390 70,628
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of December 31, 2021 and 2020 0 0
Common shares, without par value, unlimited shares authorized: 26,605,797 and 24,883,024 shares issued and outstanding as of December 31, 2021 and 2020, respectively 0 0
Additional paid-in capital 187,510 164,264
Accumulated deficit (114,740) (69,014)
Total shareholders' equity 72,770 95,250
Total liabilities and shareholders' equity 116,160 165,878
Convertible note due 2024    
Current:    
Convertible note due 2024, current portion 16,559 0
Convertible notes 1,140 0
Convertible notes due 2022    
Current:    
Convertible notes $ 0 $ 27,142